Classification of accelerated phase chronic myeloid leukemia in the era of the BCR::ABL1 tyrosine kinase inhibitors: A work in progress

Hagop Kantarjian: Research grants from Novartis, BMS, Takeda, Ascentage Pharma. Ayalew Tefferi: none. Data sharing is not applicable to this article.